Guoxin Li
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer（RC48-C018） (NCT05113459) | Guoxin Li | 2021-12-18 |
Track Guoxin Li automatically
Every clearance here is in the API, with alerts when new ones post.